Raymond James Financial Services Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $111K | Buy |
|
|||||
|
2024
Q2 | $118K | Sell |
|
|||||
|
2024
Q1 | $158K | Buy |
|
|||||
|
2023
Q4 | $82.1K | Buy |
|
|||||
|
2023
Q3 | $30.9K | Sell |
|
|||||
|
2023
Q2 | $38.2K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $30.1K | Sell |
|
|||||
|
2022
Q3 | $51K | Buy |
|
|||||
|
2022
Q2 | $33K | Sell |
|
|||||
|
2022
Q1 | $68K | Buy |
|
|||||
|
2021
Q4 | $99K | Sell |
|
|||||
|
2021
Q3 | $120K | Sell |
|
|||||
|
2021
Q2 | $179K | Sell |
|
|||||
|
2021
Q1 | $309K | Buy |
|
|||||
|
2020
Q4 | $364K | Buy |
|
|||||
|
2020
Q3 | $243K | Sell |
|
|||||
|
2020
Q2 | $325K | Buy |
|